Business
Change of Registered Office
Physiomics PLC announced a change of registered office, effective from October 1, 2025. The new registered office will be located at Milton Park Innovation Centre, 99 Park Drive, Milton Park, Oxfordshire, OX14 4RY. Disclaimer*
About this update from Physiomics Plc
[{"type":"text","content":"\n\n30 September 2025\n \nPhysiomics plc\n(\"Physiomics\" or the \"Company\")\n \nChange of Registered Office\n \nPhysiomics plc (AIM: PYC), a leading mathematical modelling, data science and biostatistics company supporting the development of new therapeutics and personalised medicine solutions, announces that, effective from 1 October 2025, its registered office will change to Milton Park Innovation Centre, 99 Park Drive, Milton Park, Oxfordshire, OX14 4RY.\nFor more information about Physiomics and its services, please visit www.physiomics.co.uk.\n \nEnquiries:\n \nPhysiomics plc\nDr Peter Sargent, CEO\n+44 (0)1235 841575\n \nHybridan LLP (Broker)\nClaire Louise Noyce\n+44 (0) 203 764 2341\n \nStrand Hanson Ltd (NOMAD)\nJames Dance & James Bellman\n+44 (0)20 7409 3494\n \n \nNotes to Editor\n \nAbout Physiomics\n \nPhysiomics plc combines expertise across Modelling & Simulation, Biostatistics, Data Science and Bioinformatics, together with deep biology expertise, to help biotech and pharma companies streamline their drug development journeys. Our approach is to help derive insight from all relevant and often disparate data in order to de-risk decision making and optimise research design across discovery, pre-clinical and clinical studies. Through use of cutting-edge computational tools, bespoke models and our proprietary Virtual Tumour technology, the Physiomics team has informed the development of over 100 commercial projects, with over 140 targets and drugs modelled. Clients include Merck KGaA, Astellas, Bicycle Therapeutics, Numab Therapeutics & CRUK. \n \n\n","length":3732,"tagName":"div"}]